Skip to main content
. 2021 Feb 19;8:635316. doi: 10.3389/fmed.2021.635316

Table 2.

Driver mutations and the transition to invasive and metastatic disease (65, 66, 69).

Genes Gene type Mutation type
BRAF (2) Oncogene Point mutation, translocations, copy number alteration
NRAS (2) Oncogene Point mutation, copy number alteration
NF1 (2) Tumor suppressor Point mutation
TERT Telomere maintenance Point mutation, copy number alteration
GNAQ Oncogene Point mutation
HRAS Oncogene Point mutation, indel
PTEN Tumor suppressor Point mutation, epigenetic silencing, copy number alteration
AKT3 Oncogene Structural rearrangement
CDKN2A Tumor suppressor Point mutation, methylation silencing, copy number alteration
CCND1 Oncogene Copy number alteration
CDK4 Oncogene Copy number alteration
RB1 Tumor suppressor Point mutation
TP53 Tumor suppressor Point mutations, copy number alteration
MDM2 Oncogene Copy number alteration
ARID2 Tumor suppressor Point mutations, copy number alteration